cobas® EGFR 変異検出キット v2.0 | ロシュ・ダイアグノスティックス
... with Advanced Non–Small Cell Lung Cancer. Jenkins S. J Thorac Oncol. 2017. EGFR mutation detection in ... clinical development of AZD9291. Thress KS. Lung Cancer. 2015. The Clinical and Economic Impact of ...
ベンタナ OptiView ALK (D5F3)｜肺癌におけるALK融合タンパクの検出に適した一次抗体｜ロシュ・ダイアグノスティックス
... rearrangement in lung cancer. Oncologist. 2015 Mar;20(3):316-22. 2. Ren S, et al. Atypical negative ALK break ... -apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer. J Thorac ... -generation sequencing for detection of EML4-ALK rearrangement in lung cancer. Oncologist. 2015 Mar;20(3):316 ... rearrangement in non-small-cell lung cancer. J Thorac Oncol. 2014 Mar;9(3):e21-3. 3. Mok T, et al. Patients with ...
ベンタナ OptiView PD-L1 (SP263)｜ロシュ・ダイアグノスティックス
... . Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017 Nov 16;377(20 ... al. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017 ...
大腸癌IHC主要製品 | ロシュ・ダイアグノスティックス
... -52. Mazziotta RM, et al. CDX2 immunostaining as a gastrointestinal marker: expression in lung ... adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Am J Clin Pathol. 2004; 122:421-7 ... lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol. 2005; 13:55-60. Saqi A, et al ... adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Am J Clin Pathol. 2004; 122:421-7 ...
ベンタナ OptiView PD-L1 (SP142)｜ロシュ・ダイアグノスティックス
... versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open ... -small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet ...
肺癌｜ロシュ・ダイアグノスティックス
... https://diagnostics.roche.com/jp/ja/products/product-category/ lung-cancer.html ...
